Fetsch P - Search Results

1

Melanoma metastatic to the breast: utility of fine needle aspiration and immunohistochemistry.

Filie AC, Simsir A, Fetsch P, Abati A. Filie AC, et al. Among authors: fetsch p. Acta Cytol. 2002 Jan-Feb;46(1):13-8. doi: 10.1159/000326709. Acta Cytol. 2002. PMID: 11843553

2

Characteristics of nine newly derived mesothelioma cell lines.

Pass HI, Stevens EJ, Oie H, Tsokos MG, Abati AD, Fetsch PA, Mew DJ, Pogrebniak HW, Matthews WJ. Pass HI, et al. Among authors: fetsch pa. Ann Thorac Surg. 1995 Apr;59(4):835-44. doi: 10.1016/0003-4975(95)00045-m. Ann Thorac Surg. 1995. PMID: 7695406

3

OV632 as a possible marker for malignant mesothelioma: high expectations; low specificity.

Abati A, Fetsch PA. Abati A, et al. Among authors: fetsch pa. Diagn Cytopathol. 1995 Feb;12(1):81-2. doi: 10.1002/dc.2840120119. Diagn Cytopathol. 1995. PMID: 7789255 No abstract available.

4

Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell lines.

Marincola FM, Shamamian P, Simonis TB, Abati A, Hackett J, O'Dea T, Fetsch P, Yannelli J, Restifo NP, Mulé JJ, et al. Marincola FM, et al. Among authors: fetsch p. J Immunother Emphasis Tumor Immunol. 1994 Jul;16(1):13-23. doi: 10.1097/00002371-199407000-00002. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8081556 Free PMC article.

5

Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions.

Marincola FM, Hijazi YM, Fetsch P, Salgaller ML, Rivoltini L, Cormier J, Simonis TB, Duray PH, Herlyn M, Kawakami Y, Rosenberg SA. Marincola FM, et al. Among authors: fetsch p. J Immunother Emphasis Tumor Immunol. 1996 May;19(3):192-205. doi: 10.1097/00002371-199605000-00004. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8811494

6

Fluorescence in situ hybridization (FISH): a user's guide to optimal preparation of cytologic specimens.

Abati A, Sanford JS, Fetsch P, Marincola FM, Wolman SR. Abati A, et al. Among authors: fetsch p. Diagn Cytopathol. 1995 Dec;13(5):486-92. doi: 10.1002/dc.2840130518. Diagn Cytopathol. 1995. PMID: 8834324

7

Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody.

Beaty MW, Fetsch P, Wilder AM, Marincola F, Abati A. Beaty MW, et al. Among authors: fetsch p. Cancer. 1997 Feb 25;81(1):57-63. doi: 10.1002/(sici)1097-0142(19970225)81:1<57::aid-cncr12>3.0.co;2-b. Cancer. 1997. PMID: 9100543

8

Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas.

Fetsch PA, Cormier J, Hijazi YM. Fetsch PA, et al. J Immunother. 1997 Jan;20(1):60-4. doi: 10.1097/00002371-199701000-00006. J Immunother. 1997. PMID: 9101414

9

Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization (FISH).

Abati A, Sanford J, Fetsch P, Pass H. Abati A, et al. Among authors: fetsch p. Diagn Cytopathol. 1997 Apr;16(4):375-7. doi: 10.1002/(sici)1097-0339(199704)16:4<375::aid-dc16>3.0.co;2-h. Diagn Cytopathol. 1997. PMID: 9143836 No abstract available.

10

Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy.

Cormier JN, Abati A, Fetsch P, Hijazi YM, Rosenberg SA, Marincola FM, Topalian SL. Cormier JN, et al. Among authors: fetsch p. J Immunother. 1998 Jan;21(1):27-31. doi: 10.1097/00002371-199801000-00003. J Immunother. 1998. PMID: 9456433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters